Retour
Fourchette du Jour
17,07 €
18,04 €
Fourchette 52 Semaines
6,36 €
25,00 €
Volume
1 896 847
Moyenne 50J / 200J
17,04 €
/
15,45 €
Clôture Précédente
17,87 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,6 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | -55,7 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
37,60 €
+110.6%
Low: 23,00 €
High: 60,00 €
BPA Prévisionnel
-3,16 €
CA Est.
1 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,17 €
-0,14 € – 8,13 €
|
1,4 B | 3 |
| FY2029 |
-0,27 €
-1,01 € – 0,02 €
|
850 M | 3 |
| FY2028 |
-2,27 €
-5,73 € – 0,61 €
|
300 M | 9 |
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -405,13M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-55,71%
ROIC-35,38%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio22,25
Interest Coverage-75,61
Valorisation
P/E Ratio
-6,60
P/B Ratio3,03
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -446,21M |
| ROE | -55,71% | ROA | -37,59% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -405,13M |
| ROIC | -35,38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 22,25 |
| Interest Coverage | -75,61 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,60 | P/B Ratio | 3,03 |
| P/S Ratio | N/A | PEG Ratio | -1,90 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,95B | Enterprise Value | 2,07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -446,21M | -317,42M | -235,94M | -168,10M | -149,29M |
| EPS (Diluted) | -3,47 | -3,37 | -3,95 | -3,23 | -2,93 |
| Gross Profit | -2,05M | -2,24M | -2,46M | 0,0 | 0,0 |
| Operating Income | -468,18M | -343,89M | -242,16M | -170,96M | -150,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,19B | 691,23M | 165,08M | 306,33M | 425,66M |
| Total Liabilities | 214,83M | 61,40M | 73,79M | 53,96M | 57,47M |
| Shareholders' Equity | 972,13M | 629,84M | 91,29M | 252,36M | 368,20M |
| Total Debt | 20,28M | 23,99M | 27,42M | 30,48M | 32,64M |
| Cash & Equivalents | 893,37M | 435,45M | 121,63M | 172,15M | 200,83M |
| Current Assets | 1,13B | 659,28M | 129,38M | 265,59M | 382,39M |
| Current Liabilities | 50,63M | 42,26M | 51,10M | 28,09M | 28,72M |